COVID-19 Pediatric Vaccine Study
Children ages 6 months to 12 years of age may be eligible to participate in a clinical study investigating a protein-based COVID-19 vaccine. Ask a doctor or click below to learn more.
Who Can Participate
● Be 6 months to 12 years
● Have never been diagnosed with COVID-19
● Have not received a vaccine to protect against COVID-19
Participants May Receive:
● Study related exam
● Study related materials
● Compensation up to $1600
We have helped tens of thousands of patients in similar studies.
Space in this study is limited. To be considered, please fill out the form or call 713-869-1825.
After you submit, a Trio Clinical patient recruitment specialist will contact you promptly.
Any information provided online or on the phone for the purpose of determining eligibility is considered confidential and will not be shared with other organizations or individuals.